Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence

Cannabis sativa L. is an annual herbaceous dioecious plant which was first cultivated by agricultural human societies in Asia. Over the period of time, various parts of the plant like leaf, flower, and seed were used for recreational as well as therapeutic purposes. The main chemical components of C...

Full description

Bibliographic Details
Main Authors: Rishabh Verma, Farazul Hoda, Mawrah Arshad, Asif Iqubal, Ali Nasir Siddiqui, Mohammad Ahmed Khan, Syed Ehtaishamul Haque, Mohd Akhtar, Abul Kalam Najmi
Format: Article
Language:English
Published: Karger Publishers 2021-05-01
Series:Medical Cannabis and Cannabinoids
Subjects:
Online Access:https://www.karger.com/Article/FullText/515042
id doaj-eb0eddf8315b4e17bd4ad813ad2f4797
record_format Article
spelling doaj-eb0eddf8315b4e17bd4ad813ad2f47972021-06-17T14:48:44ZengKarger PublishersMedical Cannabis and Cannabinoids2504-38892021-05-0141436010.1159/000515042515042Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based EvidenceRishabh Verma0https://orcid.org/0000-0002-9043-1693Farazul Hoda1Mawrah Arshad2Asif Iqubal3Ali Nasir Siddiqui4Mohammad Ahmed Khan5Syed Ehtaishamul Haque6Mohd Akhtar7Abul Kalam Najmi8Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDepartment of Pharmaceutical Medicine, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaCannabis sativa L. is an annual herbaceous dioecious plant which was first cultivated by agricultural human societies in Asia. Over the period of time, various parts of the plant like leaf, flower, and seed were used for recreational as well as therapeutic purposes. The main chemical components of Cannabis sativa are termed as cannabinoids, among them the key psychoactive constituent is Δ-9-tetrahydrocannabinol and cannabidiol (CBD) as active nonpsychotic constituent. Upon doing extensive literature review, it was found that cannabis has been widely studied for a number of disorders. Very recently, a pure CBD formulation, named Epidiolex, got a green flag from both United States Food and Drug Administration and Drug Enforcement Administration for 2 rare types of epilepsies. This laid a milestone in medical cannabis research. This review intends to give a basic and extensive assessment, from past till present, of the ethnological, plant, chemical, pharmacological, and legal aspects of C. sativa. Further, this review contemplates the evidence the studies obtained of cannabis components on Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis, multiple sclerosis, emesis, epilepsy, chronic pain, and cancer as a cytotoxic agent as well as a palliative therapy. The assessment in this study was done by reviewing in extensive details from studies on historical importance, ethnopharmacological aspects, and legal grounds of C. sativa from extensive literature available on the scientific databases, with a vision for elevating further pharmaceutical research to investigate its total potential as a therapeutic agent.https://www.karger.com/Article/FullText/515042marijuanacannabiscannabidiolalzheimerepilepsycanceremesischronic painamyotrophic lateral sclerosismultiple sclerosis
collection DOAJ
language English
format Article
sources DOAJ
author Rishabh Verma
Farazul Hoda
Mawrah Arshad
Asif Iqubal
Ali Nasir Siddiqui
Mohammad Ahmed Khan
Syed Ehtaishamul Haque
Mohd Akhtar
Abul Kalam Najmi
spellingShingle Rishabh Verma
Farazul Hoda
Mawrah Arshad
Asif Iqubal
Ali Nasir Siddiqui
Mohammad Ahmed Khan
Syed Ehtaishamul Haque
Mohd Akhtar
Abul Kalam Najmi
Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence
Medical Cannabis and Cannabinoids
marijuana
cannabis
cannabidiol
alzheimer
epilepsy
cancer
emesis
chronic pain
amyotrophic lateral sclerosis
multiple sclerosis
author_facet Rishabh Verma
Farazul Hoda
Mawrah Arshad
Asif Iqubal
Ali Nasir Siddiqui
Mohammad Ahmed Khan
Syed Ehtaishamul Haque
Mohd Akhtar
Abul Kalam Najmi
author_sort Rishabh Verma
title Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence
title_short Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence
title_full Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence
title_fullStr Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence
title_full_unstemmed Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence
title_sort cannabis, a miracle drug with polyvalent therapeutic utility: preclinical and clinical-based evidence
publisher Karger Publishers
series Medical Cannabis and Cannabinoids
issn 2504-3889
publishDate 2021-05-01
description Cannabis sativa L. is an annual herbaceous dioecious plant which was first cultivated by agricultural human societies in Asia. Over the period of time, various parts of the plant like leaf, flower, and seed were used for recreational as well as therapeutic purposes. The main chemical components of Cannabis sativa are termed as cannabinoids, among them the key psychoactive constituent is Δ-9-tetrahydrocannabinol and cannabidiol (CBD) as active nonpsychotic constituent. Upon doing extensive literature review, it was found that cannabis has been widely studied for a number of disorders. Very recently, a pure CBD formulation, named Epidiolex, got a green flag from both United States Food and Drug Administration and Drug Enforcement Administration for 2 rare types of epilepsies. This laid a milestone in medical cannabis research. This review intends to give a basic and extensive assessment, from past till present, of the ethnological, plant, chemical, pharmacological, and legal aspects of C. sativa. Further, this review contemplates the evidence the studies obtained of cannabis components on Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis, multiple sclerosis, emesis, epilepsy, chronic pain, and cancer as a cytotoxic agent as well as a palliative therapy. The assessment in this study was done by reviewing in extensive details from studies on historical importance, ethnopharmacological aspects, and legal grounds of C. sativa from extensive literature available on the scientific databases, with a vision for elevating further pharmaceutical research to investigate its total potential as a therapeutic agent.
topic marijuana
cannabis
cannabidiol
alzheimer
epilepsy
cancer
emesis
chronic pain
amyotrophic lateral sclerosis
multiple sclerosis
url https://www.karger.com/Article/FullText/515042
work_keys_str_mv AT rishabhverma cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
AT farazulhoda cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
AT mawraharshad cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
AT asifiqubal cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
AT alinasirsiddiqui cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
AT mohammadahmedkhan cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
AT syedehtaishamulhaque cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
AT mohdakhtar cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
AT abulkalamnajmi cannabisamiracledrugwithpolyvalenttherapeuticutilitypreclinicalandclinicalbasedevidence
_version_ 1721373777816715264